MAPK3 and B-cell chronic lymphocytic leukemia: MEC-1 cells were derived from a patient with CLL undergoing prolymphocytoid transformation (24) and were selected because they have readily detectable levels of constitutively active kinases, including ERK1/2 and AKT (Supplementary Fig. S1A).